Trial Identifier: | D4194R00009 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04023812 |
Start Date: | July 2019 |
Primary Completion Date: | July 2024 |
Study Completion Date: | July 2024 |
Condition: | Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
China | BeiJing, China, 100020 |
China | BeiJing, China, 100044 |
China | BeiJing, China |
China | ChangChun, China, 130021 |
China | ChengDu, China, 610041 |
China | ChengDu, China, 610042 |
China | DaTong, China, 030000 |
China | DaTong, China |
China | FenYang, China |
China | GuangZhou, China |
China | HeFei, China, 330006 |
China | HongKong, China |
China | JiNan, China, 2501117 |
China | NanNing, China, 530021 |
China | QingDao, China |
China | ShangHai, China, 200030 |
China | ShangHai, China, 200040 |
China | ShangHai, China |
China | ShanTou, China |
China | ShiJiaZhuang, China, 063000 |
China | ShiJiaZhuang, China, 430079 |
China | ShiJiaZhuang, China, 050011 |
China | TaiZhou, China |
China | TianJin, China |
China | YinChuan, China, 750004 |